scispace - formally typeset
A

Amita Aggarwal

Researcher at Sanjay Gandhi Post Graduate Institute of Medical Sciences

Publications -  374
Citations -  7291

Amita Aggarwal is an academic researcher from Sanjay Gandhi Post Graduate Institute of Medical Sciences. The author has contributed to research in topics: Arthritis & Medicine. The author has an hindex of 40, co-authored 335 publications receiving 6194 citations. Previous affiliations of Amita Aggarwal include All India Institute of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Natural products as a gold mine for arthritis treatment

TL;DR: Several preclinical and clinical studies suggest that these agents have potential for arthritis treatment, and the large number of inexpensive natural products that can modulate inflammatory responses, but lack side effects, constitute 'goldmines' for the treatment of arthritis.
Journal ArticleDOI

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study

TL;DR: The Quantitative Standard Monitoring of Patients with RA (QUEST-RA) multinational database of 8,039 patients in 86 sites in 32 countries, 16 with high gross domestic product (GDP) and 16 low-GDP countries, analyzed for work and disability status at onset and over the course of RA and clinical status of patients who continued working or had stopped working according to all RA Core Data Set measures.
Journal Article

Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases.

TL;DR: Increased IL-17 levels in ERA SF correlate with disease activity and this may be due to increased production of MMP and cytokines by IL- 17.
Journal Article

Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy.

TL;DR: Increased IL-17, IL-6, TGF-beta, and IFN-g concentrations in ReA/uSpA than in RA suggest that Th1 and Th17 cells could be the major agents in inflammation in Re a/u spondyloarthropathy.